CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q3 FY23 results · Oct–Dec 2022
CLNINDIA reported revenue from operations of ₹178.26 crore (down 19.6% from Q3 FY22) and net profit of ₹6.72 crore (down 20.5% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 178.26 | 221.81 | −19.6% | 188.41 | −5.4% |
| Other income | 0.90 | 0.18 | +400.0% | 1.74 | −48.3% |
| Total income | 179.16 | 221.99 | −19.3% | 190.15 | −5.8% |
| Profit before tax | 8.58 | 11.47 | −25.2% | 4.40 | +95.0% |
| Net profit for the period | 6.72 | 8.45 | −20.5% | (7.73) | Turned profit |
| EPS, basic (₹) | 2.91 | 3.66 | −20.5% | (3.35) | Turned profit |
| Net margin (%) | 3.8 | 3.8 | -4.1 |
Standalone
- Filed with BSE
- 07 Feb 2023, 18:07 IST
- Board meeting
- 03 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE